Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)NCT05550207AXSMPhase 3Completed2024-11-27Actual
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117MacroGenicsPhase 2Terminated2024-07-04Actual
A Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaNCT05552326IONSPhase 3Completed2024-12-17Actual
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum DisorderNCT05555615ACADPhase 2, Phase 3Terminated2025-02-14Actual
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease AgitationNCT05557409AXSMPhase 3Completed2024-11-21Actual
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza ANCT05567783VIRPhase 2Terminated2023-05-05Actual
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the BodyNCT05568095RCUSPhase 3Completed2026-08-28Actual
A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.NCT05568706ENTAPhase 2Completed2025-06-23Actual
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)NCT05571059Cumberland PharmaceuticalsPhase 2Recruiting2028-01Estimated
Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisNCT05579899EVMNPhase 2Completed2023-07-27Actual
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)NCT05580562Jazz PharmaceuticalsPhase 3Recruiting2028-06Estimated
Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia AreataNCT05589610EquilliumPhase 2Completed2024-03-26Actual
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID ConditionsNCT05592418AIMPhase 2Completed2023-11-17Actual
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) MutationNCT05593328Cardiff OncologyPhase 2Completed2024-12-09Actual
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque PsoriasisNCT05600036ALMSPhase 2Completed2023-06-29Actual
A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)NCT05606614TSHAPhase 3Active not recruiting2031-06Estimated
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNCT05607004ATOSPhase 2Active not recruiting2026-11Estimated
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)NCT05607550AVBPPhase 3Active not recruiting2025-08-15Estimated
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal CancerNCT05608044AGENPhase 2Active not recruiting2027-09Estimated
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe HypertriglyceridemiaNCT05610280IONSPhase 3Completed2024-08-08Actual
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaNCT05611931KPTIPhase 3Active not recruiting2026-08Estimated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresNCT05614063XENEPhase 3Completed2026-01-12Actual
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa InfectionNCT05616221ARMPPhase 2Completed2024-07-17Actual
A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19NCT05616728ENTAPhase 2Completed2023-02-08Actual
A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.NCT05619328Procter and GamblePhase 3Completed2023-11-02Actual
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)NCT05619692SUPNPhase 2Completed2024-06-05Actual
Extension Study Evaluating The Safety And Tolerability of AMX0035NCT05619783AMLXPhase 3Completed2024-10-16Actual
Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)NCT05621252PLRXPhase 2Completed2023-12-27Actual
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268COMPASS PathwaysPhase 3Completed2025-05-28Actual
A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy VolunteersNCT05626803VaxartPhase 2Completed2023-10-16Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.